China eases restrictions on device imports, charting a win for the industry
22 December 2014
As med tech companies set their sails toward China, a new trade agreement between the U.S. and Chinese governments looks to ease restrictions for imports, paving the way for greater expansion by U.S. devicemakers.
Record Pharma-Deal Year Not Enough to Sell Mature Drugs
22 December 2014
In a record year for health-care acquisitions, some of the largest pharmaceutical companies tried to sell their portfolios of older drugs -- and failed. Drug companies have agreed to about $260 billion of deals so far in 2014, the most since at least 2002 and more than twice the volume last year, according to data compiled by Bloomberg.
U.K. building $85M cell therapy manufacturing operation
19 December 2014
The Cell Therapy Catapult is part of a government program created a couple of years ago to pump up the cell therapy industry in the U.K. The group plans to invest more than $85 million to build a large-scale cell manufacturing facility in Stevenage that companies can contract with for early-stage to commercial work.
IMS Institute: Global drug spending is up on substantial boost from U.S.
19 December 2014
IMS Institute for Healthcare Informatics is out with its latest prediction for sales of medicines through 2018, when global spending is expected to reach between $1.28 trillion and $1.31 trillion, an increase of $290 million to $320 million over 2013 levels.
Global population living six years longer than in 1990 - study
19 December 2014
Global life expectancy has risen by more than six years since 1990 thanks to falling death rates from cancer and heart disease in rich countries and better survival in poor countries from diarrhoea, tuberculosis and malaria.
Senate Bill Offers 15 Years of Data Exclusivity for Drugs for Unmet Needs
18 December 2014
A bill was introduced in the U.S. Senate late last week that would provide a drug maker with an unprecedented 15 years of data exclusivity for a medicine that meets an unmet medical need. Specifically, this refers to the amount of time during which a generic drug maker would be prevented from using the data generated by a brand-name drug maker to then obtain regulatory approval and sell its own similar medicine.
The demand for drugs in Russian pharmacies grew by 15-20 percent over the past two months
18 December 2014
The demand for drugs in Russian pharmacies grew by 15-20 percent over the past two months compared to the same period in 2013, according to TASS referring to the research of the Centre of Social Economy.
The top 10 patent losses of 2015
18 December 2014
We have bad news and good news about patent expirations next year. The bad? When you tot up the billions of sales at risk of patent expiration in 2015, the result is $44 billion, the biggest number since the debacle of 2012. That year, $53 billion worth of drugs fell off patent--and many drugmakers are still reeling.
Study: Patients don't know how to use drug delivery devices
18 December 2014
The evidence is clear: Patients don't properly use drug delivery devices like inhalers or epinephrine autoinjectors.
17 December 2014
Twenty eight states, three territories and the District of Columbia will receive over $665 million in Affordable Care Act funding to design and test health care payment and service delivery models that will improve health care quality and lower costs, Health and Human Services Secretary Sylvia M. Burwell announced today.
06 September 2024
NovaMedica expands its line of products for the treatment of Alzheimer’s disease
22 August 2024
Children visited the NovaMedica Innotech pharmaceutical manufacturing facility
14 June 2024
The Russian government will support the development and production of modern drugs
16 September 2024
Russia’s Long-Lasting Flu Vaccine Undergoes Trials
16 September 2024
Moscow to Launch Digitalization Course for Students
12 September 2024
Russia has created an oral drug aimed at treating obesity and diabetes
12 September 2024